Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
ખોલો
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.21%
1,091.51
-2.30
-0.21%
—1,093.811,096.521,100.221,091.51——
SIXC
Communications
SIXC
Communications
SIXC
+0.22%
610.11
+1.34
+0.22%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.34%
1,237.98
-16.83
-1.34%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.93%
1,744.71
-16.40
-0.93%
—1,761.111,764.271,766.881,744.71——
SIXM
Financials
SIXM
Financials
SIXM
-0.37%
640.18
-2.40
-0.37%
—642.58644.87648.48640.18——
SIXR
Staples
SIXR
Staples
SIXR
-0.18%
849.58
-1.55
-0.18%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.48
-0.50
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.52%
3,260.69
+48.86
+1.52%
—3,211.833,227.213,268.383,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.69%
942.45
-6.53
-0.69%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.52%
1,466.80
-7.72
-0.52%
—1,474.521,479.031,481.041,466.80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.22%
2,397.50
+5.38
+0.22%
—2,392.122,396.952,421.222,382.32——
Q1 2026 earnings • released • EPS beat +33.72% • Revenue beat +4.71%
See results
ALNY:NASDAQ
Alnylam Pharmaceuticals, Inc.
US$296.11
-4.32%
(-13.38) 1D
US$296.11
0.00% (0.00)
After hours
Closed: 1 મે, 04:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALNY...
ખોલો
US$308.76
High
US$311.88
Low
US$295.79
Mkt. cap
૩૯.૫૧ અબજ
Avg. vol.
૧૧.૪૯ લાખ
Volume
૧૧.૩૩ લાખ
P/E ratio
૧૨૭.૧૧
52-wk high
US$495.55
52-wk low
US$238.62
EPS
US$2.33
Beta
૦.૩૯
Shares outstanding
૧૩.૩૪ કરોડ
No. of employees
૨ હજાર
News stories
From sources across the web
પ્રોફાઇલ
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals, Inc.
CEO-
Employees2.5 હજાર
Founded14 જૂન, 2002
Headquarters-
Sector-
Websitealnylam.com
Last report
30 એપ્રિલ, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
૧.૯૯/ (૧.૪૯ est.)USD
+33.72%beat
Revenue / Estimate
૧.૧૭ અબજ/ (૧.૧૧ અબજ est.)USD
+4.71%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
જૂન 2025
સપ્ટે 2025
ડિસે 2025
માર્ચ 2026
Revenue
77.37 કરોડ
1.25 અબજ
1.10 અબજ
1.17 અબજ
Cost of goods sold
14.30 કરોડ
20.02 કરોડ
26.77 કરોડ
20.75 કરોડ
Cost of revenue
14.30 કરોડ
20.02 કરોડ
26.77 કરોડ
20.75 કરોડ
Research and development expenses
32.36 કરોડ
35.88 કરોડ
37.22 કરોડ
36.85 કરોડ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32.33 કરોડ
32.21 કરોડ
32.54 કરોડ
32.26 કરોડ
Operating expense
64.69 કરોડ
68.09 કરોડ
69.76 કરોડ
69.10 કરોડ
Total operating expenses
78.99 કરોડ
88.10 કરોડ
96.53 કરોડ
89.85 કરોડ
Operating income
-1.62 કરોડ
36.80 કરોડ
13.17 કરોડ
26.86 કરોડ
Other non operating income
-50.49 લાખ
-7.42 કરોડ
9.30 કરોડ
-42.95 લાખ
EBT including unusual items
-3.54 કરોડ
23.90 કરોડ
16.11 કરોડ
22.17 કરોડ
EBT excluding unusual items
-3.40 કરોડ
27.81 કરોડ
12.20 કરોડ
22.17 કરોડ
Income tax expense
3.09 કરોડ
-1.21 કરોડ
-2.53 કરોડ
1.57 કરોડ
Effective tax rate
-87.45%
-5.07%
-15.69%
7.07%
Other operating expenses
-
-
-
-
Net income
-6.63 કરોડ
25.11 કરોડ
18.64 કરોડ
20.60 કરોડ
Net profit margin
-8.57%
20.10%
16.99%
17.65%
Earnings per share
0.32
2.90
1.25
1.99
Interest and investment income
2.75 કરોડ
2.87 કરોડ
2.66 કરોડ
2.66 કરોડ
Interest expense
-4.02 કરોડ
-4.44 કરોડ
-12.93 કરોડ
-6.93 કરોડ
Net interest expenses
-1.28 કરોડ
-1.57 કરોડ
-10.27 કરોડ
-4.27 કરોડ
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.55 લાખ
38.18 કરોડ
14.52 કરોડ
28.22 કરોડ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer